Abciximab

Category: Blood Thinner (Anticoagulant)



Abciximab Overview

Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[1] While abciximab has a short pla...

Read more Abciximab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abciximab

Recent Abciximab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abciximab
  • Injection: 2mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Abciximab or a similar ingredient: (1 result)

Related Abciximab Topics:

reopro (abciximab) for cardiac ischemic complications
ReoPro(Abciximab) is a monoclonal antibody that blocks the pathway to platelet aggregation and reduces cardiac ischemic ...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA